Skip to main content
. Author manuscript; available in PMC: 2021 Jun 10.
Published in final edited form as: Clin Immunol. 2019 Mar 26;202:49–58. doi: 10.1016/j.clim.2019.03.008

Fig. 5.

Fig. 5.

ILC1 presented potent ability to secrete IFN-γ in SLE. PBMCs from 11 healthy controls and 11 SLE patients were isolated and cultured in RPMI1640 supplemented with 10%FBS in the presence of Brelfeldin A for 6 h. Intracellular IFN-γ staining was performed. (A). Gating strategy is presented. (B). The production of IFN-γ is measured by flow cytometry in cells gated on the ILC1 population. (C, D) Comparison of intensity of IFN-γ between control and SLE groups are shown. (E) Frequencies of IFN-γ positive ILC1 in control and SLE patients groups are compared.